We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




New Electrotherapy Systems Alleviate Postoperative Pain and Edema

By HospiMedica International staff writers
Posted on 23 Dec 2008
Targeted pulsed electromagnetic field (tPEMF) devices create a therapeutic electrical current in injured soft tissue, modulating biochemical and physiological healing processes to help reduce related pain and inflammation.

The SofPulse tPEMF 912-M10, Roma, and Torino II series of products are indicated for the palliative treatment of postoperative pain and edema in superficial soft tissue, by enhancing the body's anti-inflammatory and angiogenic responses. More...
The tPEMF technology is drug-free, easy to apply, and has an excellent safety profile. The new SofPulse devices are portable, disposable, and more economical, with significantly lowered electromagnetic interference. The tPEMF signals works through clothing, dressings, and even plaster casts. The system consists of a power supply and a range of applicators; the selected applicator head is swung into position, lightly resting against the affected area (direct contact is not required). Treatments are generally given twice or three times a day, lasting for 30 minutes. The new Ivivi SofPulse devices are products of Ivivi Technologies (Northvale, NJ, USA), and have been approved by the U.S. Food and Drug Administration (FDA).

"This latest generation of Ivivi signals evolved as a result of our significant advances in understanding the mechanism of action of tPEMF," said Steven Gluckstern, Chairman, President, and CEO of Ivivi. "This knowledge and the ability to freely market the SofPulse family of products for its labeled indications are important steps in helping Ivivi realize the full potential of this broad-based, effective electrotherapeutic treatment modality."

Pulsing electromagnetic field (PEMF) generators provide high frequency electromagnetic energy fields so powerful they can light a 40-Watt bulb, but pulse so quickly they do not heat the body significantly. Improvements have been made to electrotherapy devices in recent years, which have so far been used successfully in rhytidectomy, liposculpture, laser resurfacing, brow lifting, and facial fat grafting, as well as in rhinoplasty, abdominoplasty, and breast surgery for reducing edema and pain.

Related Links:
Ivivi Technologies


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mobile X-Ray System
K4W
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.